PROCAN SR Drug Patent Profile
✉ Email this page to a colleague
When do Procan Sr patents expire, and what generic alternatives are available?
Procan Sr is a drug marketed by Parke Davis and Parkedale and is included in four NDAs.
The generic ingredient in PROCAN SR is procainamide hydrochloride. There is one drug master file entry for this compound. Eleven suppliers are listed for this compound. Additional details are available on the procainamide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Procan Sr
A generic version of PROCAN SR was approved as procainamide hydrochloride by INTL MEDICATION on July 31st, 1984.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PROCAN SR?
- What are the global sales for PROCAN SR?
- What is Average Wholesale Price for PROCAN SR?
Summary for PROCAN SR
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 100 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,413 |
| DailyMed Link: | PROCAN SR at DailyMed |
Recent Clinical Trials for PROCAN SR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Pittsburgh | N/A |
| Evan Adelstein, MD | N/A |
| UPMC | N/A |
US Patents and Regulatory Information for PROCAN SR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parke Davis | PROCAN SR | procainamide hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 086468-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Parkedale | PROCAN SR | procainamide hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 087510-001 | Apr 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Parkedale | PROCAN SR | procainamide hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 088489-001 | Jan 16, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Parkedale | PROCAN SR | procainamide hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 086065-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
